Short Interval Versus Long Interval Repeated Extracorporeal Shockwave Lithotripsy (ESWL) for 8-15 mm Renal Stones.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Extracorporeal shockwave lithotripsy (ESWL).
- Who it may be relevant to
- Registry conditions: Kidney Stone. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Sweden
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Double Extracorporeal Shockwave Lithotripsy for Renal Stones.
Overview
Extracorporeal shockwave lithotripsy (ESWL) is one way to treat renal stones. In this clinical trial our goal is to evaluate if two ESWL the same week is equal good and safe to two ESWL 3 weeks regarding renal stones 8-15 mm.
Detailed description
All patients with a renal stone 8-15 mm are asked to participate. If they give consent they are randomized to ESWL with an interval of 2 days or 3 weeks. Data regarding age, gender, stone size, Hounsfield unit, skin to stone distance, urine culture, results from the follow up CT and need for auxillary interventions are extraced from the medical records.
Interventions
- Procedure Extracorporeal shockwave lithotripsy (ESWL)
ESWL, two treatments with an interval of two days or three weeks.
Primary outcome measures
- Time to stone free status [Time frame: From enrollment until closure]
- Complications [Time frame: From enrollment until closure]
- Number of participants considered stone free at follow up [Time frame: From enrollment until closure.]
Secondary outcome measures (1)
- Participant´s experiences [Time frame: From enrollment until closure]
Eligibility criteria
Inclusion Criteria: All patients with a renal stone 8-15 mm who are planned for intervention -
Exclusion Criteria: Those who decline to participate, those who are put under guardianship or is less than 18 years old.
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Sweden · 2 centers
- Department of Urology — Helsingborg
- Department of Urology, KI Huddinge — Stockholm
Identifiers
NCT: NCT07421843 · 2022-00035-01